1033.8000 -0.70 (-0.07%)
NSE Sep 17, 2025 15:31 PM
Volume: 754.2K
 

logo
Zydus Lifesciences Ltd.
18 Aug 2017, 12:00AM
1033.80
-0.07%
Axis Direct
Q1FY18 EBITDA margin declined 1,000 bps YoY/ 590 bps QoQ to 12.4% on negative operating leverage, as India sales declined 19% YoY. EBITDA margin adj. for GST stood at ~18%. US sales grew 3% QoQ in USD terms aided by full quarter consolidation of Sentynl.
Zydus Lifesciences L.. has an average target of 1045.33 from 6 brokers.
More from Zydus Lifesciences Ltd.
Recommended